More Press Releases related to this journal
Edited by: Jan A. Nolta
Print ISSN: 1066-5099 Online ISSN: 1549-4918
Published on behalf of AlphaMed Press
Impact Factor: 5.587

More Press Releases in:

Medicine & Healthcare

June 07, 2016

Stem Cells from Umbilical Cord Blood May Help Treat Eczema

A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis.


For the clinical trial, 34 patients were randomly assigned to receive a low dose or high dose of the cells subcutaneously. Fifty five percent of patients who received the high dose showed a 50% reduction in what’s known as the Eczema Area and Severity Index score at week 12. Immune-related markers of atopic dermatitis also decreased significantly.


“This study is a first-in-class study demonstrating that adults with moderate-to-severe atopic dermatitis responded to a treatment of stem cells derived from umbilical cord blood,” said Dr. Tae-Yoon Kim, senior author of the Stem Cells study. “The single treatment of stem cells in patients resulted in the significant and persistent improvement in disease symptoms throughout the follow-up period of 12 weeks.” 


The study was conducted at Seoul St. Mary’s Hospital in collaboration with Seoul National University (with co-senior author, Dr. Kyung-Sun Kang).